Latest period
394M
YoY change
-1.7%
5Y CAGR
+0.8%
Peak year (FY2021)
429M
Latest annual
406M
Shares Outstanding history chart for DexCom (DXCM) from 2016 to 2025
Latest: 406M
Shares Outstanding growth chart for DexCom (DXCM) from 2016 to 2025
Latest: -1.7%
Shares Outstanding history table for DexCom (DXCM) from 2000 to 2025
| FY2025 | 406M | -1.7% | -7.2M | ||
| FY2024 | 413M | -3.0% | -12.8M | ||
| FY2023 | 426M | -0.5% | -2M | ||
| FY2022 | 428M | -0.3% | -1.3M | ||
| FY2021 | 429M | +9.9% | +38.8M | ||
| FY2020 | 390M | +5.6% | +20.8M | ||
| FY2019 | 369M | +4.6% | +16.4M | ||
| FY2018 | 353M | +2.2% | +7.6M | ||
| FY2017 | 345M | +3.2% | +10.8M | ||
| FY2016 | 334M | +4.8% | +15.2M | ||
| FY2015 | 319M | +6.1% | +18.4M | ||
| FY2014 | 301M | +5.8% | +16.4M | ||
| FY2013 | 284M | +3.5% | +9.6M | ||
| FY2012 | 275M | +4.7% | +12.4M | ||
| FY2011 | 262M | +15.3% | +34.8M | ||
| FY2010 | 228M | +28.3% | +50.2M | ||
| FY2009 | 177M | +50.4% | +59.4M | ||
| FY2008 | 118M | +4.1% | +4.7M | ||
| FY2007 | 113M | +4.0% | +4.31M | ||
| FY2006 | 109M | +43.8% | +33.2M | ||
| FY2005 | 75.8M | +728.7% | +66.6M | ||
| FY2004 | 9.14M | +5.3% | +464K | ||
| FY2003 | 8.68M | +6.0% | +495K | ||
| FY2002 | 8.18M | +7.9% | +599K | ||
| FY2001 | 7.59M | +9.8% | +678K | ||
| FY2000 | 6.91M | — | — |
- FY2025406M-1.7%
- FY2024413M-3.0%
- FY2023426M-0.5%
- FY2022428M-0.3%
- FY2021429M+9.9%
- FY2020390M+5.6%
- FY2019369M+4.6%
- FY2018353M+2.2%
- FY2017345M+3.2%
- FY2016334M+4.8%
- FY2015319M+6.1%
- FY2014301M+5.8%
- FY2013284M+3.5%
- FY2012275M+4.7%
- FY2011262M+15.3%
- FY2010228M+28.3%
- FY2009177M+50.4%
- FY2008118M+4.1%
- FY2007113M+4.0%
- FY2006109M+43.8%
- FY200575.8M+728.7%
- FY20049.14M+5.3%
- FY20038.68M+6.0%
- FY20028.18M+7.9%
- FY20017.59M+9.8%
- FY20006.91M—
Shares Outstanding values are taken from DexCom's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's latest reported diluted shares outstanding is 394M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of DexCom (DXCM) diluted shares outstanding is 406M – edged down 1.7% year-over-year.
Across 2020–2025 (5 years), DexCom diluted shares outstanding produced a CAGR of +0.8% – with mixed annual results across the window.
DexCom diluted shares outstanding declined from 429M in 2021 to 406M in 2025, a 5.4% drawdown.
2021 marks the peak diluted shares outstanding at 429M, with the historical low of 6.91M recorded in 2000.
DexCom Shares Outstanding by Year
DexCom Shares Outstanding 2025: 406M
DexCom diluted shares outstanding in 2025 was 406M, edged down 1.7% below 2024.
DexCom Shares Outstanding 2024: 413M
2024's diluted shares outstanding for DexCom came in at 413M, edged down 3.0% below 2023.
DexCom Shares Outstanding 2023: 426M
DexCom posted diluted shares outstanding of 426M in 2023, edged down 0.5% below 2022.
DexCom Shares Outstanding 2022: 428M
In 2022, DexCom reported diluted shares outstanding of 428M, edged down 0.3% below 2021.
DexCom Shares Outstanding 2021: 429M
DexCom diluted shares outstanding in 2021 was 429M.
See more financial history for DexCom (DXCM).
Sector peers by Shares Outstanding
Healthcare peers of DexCom (DXCM), ranked by their latest diluted shares outstanding
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.